Literature DB >> 12060183

Thalamic and caudate volumes in monozygotic twins discordantfor schizophrenia.

Nicola Bridle1, Christos Pantelis, Stephen J Wood, Richard Coppola, Dennis Velakoulis, Michael McStephen, Paul Tierney, Thai L Le, E Fuller Torrey, Daniel Weinberger.   

Abstract

OBJECTIVE: The thalamus and caudate nucleus are key subcortical structures in the fronto-striato-thalamic pathways that have been implicated in the pathogenesis of schizophrenia. Previous studies have been inconsistent in identifying structural and functional abnormalities in these structures. However, methodologies in these studies have been unreliable and some have not adequately matched patients and controls.
METHODS: Using algebraically-manipulated double-echomagnetic resonance (MR) images, we developed a reliable method to estimate caudate and thalamic volumes in a group of 13 monozygotic(MZ) twins; eight discordant for schizophrenia and five normal.Initially, volumes were measured on four image types: proton density(PD), T2-weighted, summed (PD + T2) and subtracted (PD-T2) to determine the most reliable method.
RESULTS: There was a significant method by region interaction, where caudate volumes measured on PD images were significantly larger than those measured on T2-weighted images, while the opposite was found for thalamic volumes. However, there was no interaction of method by diagnosis. Test-retest reliability was highest for the summed images. Using summed images to measure the volumes of the caudate and thalamus in each twin, we found significantly increased caudate volumes in affected twins compared to their unaffected cotwins,but no significant difference in thalamic volume.
CONCLUSIONS: Our results in a small sample of MZ twins discordant for schizophrenia do not support the presence of structural abnormalities in the thalamus. The findings in the caudate are consistent with previously reported effects of antipsychotic medication. We also report a reliable method for assessing the volumes of subcortical structures. However, volumetric estimates of brain structures may be dependent on which method is used and the structure being assessed. Such interactions need to be considered in future studies investigating brain structural abnormalities in schizophrenia and other disorders.

Entities:  

Mesh:

Year:  2002        PMID: 12060183     DOI: 10.1046/j.1440-1614.2001.01022.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  5 in total

Review 1.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

2.  Optimizing hippocampal segmentation in infants utilizing MRI post-acquisition processing.

Authors:  Deanne K Thompson; Zohra M Ahmadzai; Stephen J Wood; Terrie E Inder; Simon K Warfield; Lex W Doyle; Gary F Egan
Journal:  Neuroinformatics       Date:  2012-04

3.  Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings.

Authors:  Robyn A Honea; Andreas Meyer-Lindenberg; Katherine B Hobbs; Lukas Pezawas; Venkata S Mattay; Michael F Egan; Beth Verchinski; Richard E Passingham; Daniel R Weinberger; Joseph H Callicott
Journal:  Biol Psychiatry       Date:  2007-08-08       Impact factor: 13.382

4.  Effects of the neurogranin variant rs12807809 on thalamocortical morphology in schizophrenia.

Authors:  Jamie Yu Jin Thong; Anqi Qiu; Min Yi Sum; Carissa Nadia Kuswanto; Ta Ahn Tuan; Gary Donohoe; Yih Yian Sitoh; Kang Sim
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

5.  Brain features of nearly drug-naïve female monozygotic twins with first-episode schizophrenia and the classification accuracy of brain feature patterns: A pilot study.

Authors:  Tao Zhang; Jie Song; Ce Chen; Ran Li; Yachen Li; Yun Sun; Tao Fang; Weiwei Xu; Hongjun Tian; Chuanjun Zhuo
Journal:  Brain Behav       Date:  2020-12-08       Impact factor: 3.405

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.